HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 87 filers reported holding HARVARD BIOSCIENCE INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,229,465 | -21.9% | 285,922 | -0.3% | 0.51% | -16.7% |
| Q2 2023 | $1,575,202 | +28.8% | 286,922 | -1.5% | 0.61% | +21.0% |
| Q1 2023 | $1,223,448 | +50.6% | 291,297 | -0.7% | 0.50% | +44.3% |
| Q4 2022 | $812,433 | +6.3% | 293,297 | -1.7% | 0.35% | +1.4% |
| Q3 2022 | $764,000 | -28.9% | 298,297 | -0.1% | 0.34% | -25.0% |
| Q2 2022 | $1,075,000 | -40.3% | 298,697 | +2.9% | 0.46% | -27.7% |
| Q1 2022 | $1,802,000 | -11.9% | 290,197 | 0.0% | 0.64% | -5.5% |
| Q4 2021 | $2,046,000 | -0.5% | 290,197 | -1.5% | 0.67% | -3.2% |
| Q3 2021 | $2,057,000 | -16.2% | 294,697 | 0.0% | 0.70% | -13.4% |
| Q2 2021 | $2,455,000 | +52.4% | 294,697 | -0.1% | 0.80% | +38.0% |
| Q1 2021 | $1,611,000 | -74.7% | 295,072 | -80.1% | 0.58% | +15.9% |
| Q4 2020 | $6,360,000 | +42.4% | 1,482,860 | -0.1% | 0.50% | +6.1% |
| Q3 2020 | $4,465,000 | -4.1% | 1,483,610 | -1.2% | 0.47% | -8.5% |
| Q2 2020 | $4,655,000 | +573.7% | 1,501,360 | +380.0% | 0.52% | +1.6% |
| Q1 2020 | $691,000 | -27.2% | 312,772 | +0.5% | 0.51% | +5.4% |
| Q4 2019 | $949,000 | -1.0% | 311,122 | -0.3% | 0.48% | -1.0% |
| Q3 2019 | $959,000 | +50.5% | 311,922 | -2.1% | 0.49% | +53.5% |
| Q2 2019 | $637,000 | -53.6% | 318,497 | -0.1% | 0.32% | -54.0% |
| Q1 2019 | $1,373,000 | +34.1% | 318,672 | -1.0% | 0.69% | +16.9% |
| Q4 2018 | $1,024,000 | -88.0% | 321,972 | -80.3% | 0.59% | -25.1% |
| Q3 2018 | $8,560,000 | -2.8% | 1,630,360 | -0.9% | 0.79% | -3.3% |
| Q2 2018 | $8,805,000 | +429.1% | 1,645,360 | +394.4% | 0.82% | -1.4% |
| Q1 2018 | $1,664,000 | +45.2% | 332,772 | -4.2% | 0.83% | +50.7% |
| Q4 2017 | $1,146,000 | -12.4% | 347,372 | -0.4% | 0.55% | -9.7% |
| Q3 2017 | $1,308,000 | +45.8% | 348,872 | -0.8% | 0.61% | +49.6% |
| Q2 2017 | $897,000 | -80.4% | 351,822 | -80.0% | 0.41% | -4.2% |
| Q1 2017 | $4,575,000 | +317.0% | 1,759,110 | +389.3% | 0.42% | -16.5% |
| Q4 2016 | $1,097,000 | +10.8% | 359,525 | -1.3% | 0.51% | +5.4% |
| Q3 2016 | $990,000 | -5.3% | 364,125 | -0.3% | 0.48% | -12.8% |
| Q2 2016 | $1,045,000 | -8.4% | 365,325 | -3.3% | 0.55% | -15.7% |
| Q1 2016 | $1,141,000 | -8.0% | 377,925 | +5.7% | 0.66% | -10.1% |
| Q4 2015 | $1,240,000 | -13.3% | 357,475 | -5.5% | 0.73% | -11.2% |
| Q3 2015 | $1,430,000 | -34.7% | 378,225 | -1.6% | 0.82% | -24.3% |
| Q2 2015 | $2,191,000 | -4.6% | 384,425 | -2.6% | 1.09% | -1.4% |
| Q1 2015 | $2,297,000 | +0.9% | 394,725 | -1.6% | 1.10% | +3.6% |
| Q4 2014 | $2,276,000 | +38.3% | 401,325 | -0.2% | 1.06% | +38.2% |
| Q3 2014 | $1,646,000 | -10.2% | 402,325 | -0.1% | 0.77% | +6.2% |
| Q2 2014 | $1,832,000 | -4.7% | 402,725 | -0.7% | 0.72% | -10.8% |
| Q1 2014 | $1,923,000 | +0.5% | 405,725 | -0.5% | 0.81% | +2.1% |
| Q4 2013 | $1,914,000 | -11.5% | 407,725 | -0.9% | 0.80% | -16.8% |
| Q3 2013 | $2,163,000 | +11.9% | 411,225 | -0.0% | 0.96% | +5.9% |
| Q2 2013 | $1,933,000 | – | 411,375 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |